 
                                
                                About Cobimetinib Cobimetinib is a MEK inhibitor. Cobimetinib is an anti-cancer medication used to treat melanoma and histiocytic neoplasms. Melanoma Indicated…
 
                                
                                Tunlametinib (HL-085) is an oral, selective, mitogen-activated protein kinase kinase 1 and 2 (MEK 1/2) inhibitor, for…
 
                                
                                About Vemurafenib Vemurafenib is a medication used for the treatment of late-stage melanoma. It is an inhibitor of the B-Raf enzyme. Malignant…
 
                                
                                About Encorafenib Encorafenib is a medication used for the treatment of certain melanoma cancers. It is a small molecule BRAF inhibitor that targets…
 
                                
                                Melanoma Indicated in combination with encorafenib for patients with unresectable or metastatic melanoma with a BRAF…
 
                                
                                Trametinib is a kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers…
 
                                
                                Dabrafenib is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the…